cerevisiae strain MTY483, protein expression was studied, and proteins were extracted, as previously described (Tabuchi et al., 2009). Ten micrograms of total protein was separated by 10% SDS-PAGE. The gels were electroblotted onto PVDF membrane (pore size, 0.45 μm) and incubated with human serum (1 : 200 dilution)

as primary antibodies. Horseradish peroxidase (HRP)-conjugated goat GSK-3 beta pathway anti-human IgA + IgG + IgM immunoglobulin (KPL, MD) and goat anti-human IgA (Monosan, Netherland), IgG (Invitrogen, CA), and IgM (Invitrogen) were used at a dilution of 1 : 3000 as the secondary antibodies. Immunoreactive bands were visualized by Immobilon Western (Millipore, MA) with an LAS-1000 imaging system. The membranes were reprobed with anti-GFP antibody (1 : 5000 dilution; Tabuchi et al., 2010) and HRP-labeled anti-rabbit IgG (1 : 5000 dilution: Cell Signaling Technology, MA). Thirteen serum samples from eight patients were tested with the commercially available HITAZYME and Medac ELISA kits (Table 1). Pexidartinib nmr All samples tested positive for at least one anti-C. pneumoniae antibody. However, some discrepancies were observed between the HITAZYME and Medac kits. To identify novel C. pneumoniae

antigens, we expressed 455 unique GFP-tagged ORFs encoded by the C. pneumoniae J138 genome (Table S1). Of these clones, the expression of 398 clones was recognized by anti-GFP antibody, although the levels of expression varied in each yeast clone (Fig. 1a). The expression of the remaining 57 clones was undetectable by anti-GFP antibody for unclear reasons. We attempted to comprehensively identify the antigens by Western blot analysis using a pool of 13 serum samples as the primary antibody and four different immunoglobulins as the secondary antibodies.

As an example, the expression of eight ORFs of C. pneumoniae genes is shown in Fig. 1. The serum samples from these patients did not contain significant anti-S. cerevisiae antibodies that would have produced a Cyclin-dependent kinase 3 high-level background on the Western blots. Therefore, we were able to specifically detect the C. pneumoniae antigens recognized by human anti-C. pneumoniae antibodies under conditions of low-level background. Positive signals were detected in the yeast clones expressing Cpj1056 and Cpj1070 ORFs when anti-human IgA + IgG + IgM immunoglobulin and anti-human IgG were used as secondary antibodies (Fig. 1b and d). The recombinant proteins derived from the ORFs Cpj1056 and Cpj1070 were estimated to be 55 and 81 kDa, respectively, which were matched well with the molecular weights predicted from the sequences of C. pneumoniae when they were fused with GFP. The other six ORFs were not detected on these blots and remained ‘negative’ throughout this investigation. Among the 398 recombinant ORF clones, 58 clones gave positive signals on Western blots when probed with the pool of 13 serum samples (Fig. 2). The ORF clones that gave positive signals varied with each type of secondary antibody.